mobile search

HKEX Holds Israel Day Conference

18 May 2017

  • HKEX explains benefits of listing in Hong Kong to Israeli enterprises
  • Israeli enterprises showcase their technologies
  • 200+ guests include Consul General of Israel in Hong Kong and Macau


Hong Kong Exchanges and Clearing Limited (HKEX) held a conference in Hong Kong today (Thursday) to explain the benefits of listing in Hong Kong for Israeli enterprises.

Sagi Karni, Consul General of Israel in Hong Kong and Macau, attended the conference, entitled "Israel Day at HKEX", along with more than 200 other guests representing a diverse group of institutional investors, Hong Kong-listed companies, market intermediaries and companies from Israel.

The event was organised together with the Hong Kong Venture Capital and Private Equity Association, PwC, Meitav Dash, an investment firm based in Israel, and Israeli law firm  Weinstock Zecler & Co, with supporting organisations InvestHK, the Hong Kong Securities and Investment Institute and the Consulate of Israel in Hong Kong and Macau.

Speakers from buy-side funds, sell-side teams and intermediaries shared their experience along with their insights and views about investment and listing opportunities in Hong Kong for Israeli enterprises.  There was also an opening keynote by HKEX Head of Group Strategy and Project Management, James Fok, who explained the latest developments in HKEX's securities market and the advantages of a Hong Kong listing for Israeli enterprises, especially firms in the high growth technology sector.

Israeli companies featured at the conference showcased their technologies and had individual small-group meetings with institutional investors, senior executives of Hong Kong listed companies and market practitioners who attended the event.

"The China and international dimensions of our securities market have helped bring IPOs (initial public offerings) from the Mainland as well as overseas to Hong Kong," Mr Fok said. "As Israeli companies look for business opportunities outside their home market, they can raise funds while gaining visibility in one of the world’s largest economies by listing on our Stock Exchange."

"We will continue to work closely with Israeli enterprises to strengthen their understanding of HKEX and the Hong Kong market, as well as to help them best position themselves to reap the benefits from a Hong Kong listing," said Sandra Leung, HKEX Head of Issuer Services.

Please see the appendix for background information and a list of Israeli enterprises represented at today's conference.



Background information

  • Israel has one of the largest pools of "new economy" (eg, technology, biotech, healthcare) companies globally, second only to the US.
  • In recent years, there has been increased collaboration and fund flows between Hong Kong's investor community and Israeli companies looking eastward for Asian partnerships.
  • On 17 March 2017, HKEX formally approved Israel as an acceptable overseas jurisdiction and published an Israel country guide, making Hong Kong a convenient place for companies incorporated in Israel to list. 

Israeli enterprises represented at today's conference

Name Sector
BiolinerRX Healthcare
Evogene Agricultural Technology
eyeSight Technology
Freightos Logistic Technology
Galmed Pharmaceuticals Healthcare
Luminati Technology
Metzer Agricultural Technology
NovellusDx Healthcare
NRGene Healthcare
Oramed Pharmaceuticals Healthcare
Perflow Medical Healthcare
Strauss Group Healthcare


Sagi Karni, Consul General of Israel in Hong Kong and Macau, addresses today's conference.


James Fok, HKEX Head of Group Strategy and Project Management, explains the benefits of listing in Hong Kong.


The panellists share their insights with Israeli enterprises about listing opportunities in Hong Kong.


Updated 18 May 2017